Markovitz DM - Search Results

1

Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.

Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM. Contreras-Galindo R, et al. Among authors: markovitz dm. J Virol. 2012 Jan;86(1):262-76. doi: 10.1128/JVI.00602-11. Epub 2011 Oct 26. J Virol. 2012. PMID: 22031938 Free PMC article.

2

Non-targeted isomer-sensitive N-glycome analysis reveals new layers of organ-specific diversity in mice.

Stadlmann J, Helm J, Mereiter S, Oliveira T, Gattinger A, Markovitz D, Penninger J, Altmann F. Stadlmann J, et al. Res Sq [Preprint]. 2024 Apr 9:rs.3.rs-4130712. doi: 10.21203/rs.3.rs-4130712/v1. Res Sq. 2024. Update in: Nat Commun. 2024 Nov 9;15(1):9725. doi: 10.1038/s41467-024-54134-z PMID: 38659835 Free PMC article. Updated. Preprint.

3

Failure of recommended treatment for secondary syphilis.

Markovitz DM, Beutner KR, Maggio RP, Reichman RC. Markovitz DM, et al. JAMA. 1986 Apr 4;255(13):1767-8. JAMA. 1986. PMID: 3951104 No abstract available.

4

Activation of the human immunodeficiency virus type 2 enhancer is dependent on purine box and kappa B regulatory elements.

Markovitz DM, Smith MJ, Hilfinger J, Hannibal MC, Petryniak B, Nabel GJ. Markovitz DM, et al. J Virol. 1992 Sep;66(9):5479-84. doi: 10.1128/JVI.66.9.5479-5484.1992. J Virol. 1992. PMID: 1501284 Free PMC article.

5

Leiden JM, Wang CY, Petryniak B, Markovitz DM, Nabel GJ, Thompson CB. Leiden JM, et al. Among authors: markovitz dm. J Virol. 1992 Oct;66(10):5890-7. doi: 10.1128/JVI.66.10.5890-5897.1992. J Virol. 1992. PMID: 1527846 Free PMC article.

6

Activation of the human immunodeficiency virus type 1 enhancer is not dependent on NFAT-1.

Markovitz DM, Hannibal MC, Smith MJ, Cossman R, Nabel GJ. Markovitz DM, et al. J Virol. 1992 Jun;66(6):3961-5. doi: 10.1128/JVI.66.6.3961-3965.1992. J Virol. 1992. PMID: 1533884 Free PMC article.

7

The peri-kappa B site mediates human immunodeficiency virus type 2 enhancer activation in monocytes but not in T cells.

Clark NM, Hannibal MC, Markovitz DM. Clark NM, et al. Among authors: markovitz dm. J Virol. 1995 Aug;69(8):4854-62. doi: 10.1128/JVI.69.8.4854-4862.1995. J Virol. 1995. PMID: 7609053 Free PMC article.

8

Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.

Hannibal MC, Markovitz DM, Clark N, Nabel GJ. Hannibal MC, et al. Among authors: markovitz dm. J Virol. 1993 Aug;67(8):5035-40. doi: 10.1128/JVI.67.8.5035-5040.1993. J Virol. 1993. PMID: 8331739 Free PMC article.

9

Activation of the human T-cell leukemia virus type I enhancer is mediated by binding sites for Elf-1 and the pets factor.

Clark NM, Smith MJ, Hilfinger JM, Markovitz DM. Clark NM, et al. Among authors: markovitz dm. J Virol. 1993 Sep;67(9):5522-8. doi: 10.1128/JVI.67.9.5522-5528.1993. J Virol. 1993. PMID: 8350410 Free PMC article.

10

Differential regulation of the human immunodeficiency virus type 2 enhancer in monocytes at various stages of differentiation.

Hilfinger JM, Clark N, Smith M, Robinson K, Markovitz DM. Hilfinger JM, et al. Among authors: markovitz dm. J Virol. 1993 Jul;67(7):4448-53. doi: 10.1128/JVI.67.7.4448-4453.1993. J Virol. 1993. PMID: 8510231 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

122 results

Search Page

Filters